These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 21145322

  • 1. Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonica.
    Hou XY, Ellis MK, McManus DP, Wang YY, Li SD, Williams GM, Li YS.
    Int J Parasitol; 2011 Mar; 41(3-4):325-32. PubMed ID: 21145322
    [Abstract] [Full Text] [Related]

  • 2. A simple noninvasive index to predict significant liver fibrosis in patients with advanced schistosomiasis japonica.
    Wu YM, Xu N, Hu JY, Xu XF, Wu WX, Gao SX, Zhu WJ, Wu WL, Shen XZ, Wang JY, Wu SD.
    Parasitol Int; 2013 Jun; 62(3):283-8. PubMed ID: 23466574
    [Abstract] [Full Text] [Related]

  • 3. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM, Omran D, Omran MM, Albannan MS, Zayed RA, Saif S, Farid A, Hassany M, Yosry A.
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [Abstract] [Full Text] [Related]

  • 4. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
    Schiavon LL, Narciso-Schiavon JL, Carvalho Filho RJ, Sampaio JP, Medina-Pestana JO, Lanzoni VP, Silva AE, Ferraz ML.
    J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of platelet derived growth factor-BB, transforming growth factor-beta1, matrix metalloproteinase-1, and tissue inhibitor of matrix metalloproteinase-1 in serum and peripheral blood mononuclear cells for hepatic fibrosis.
    Zhang BB, Cai WM, Weng HL, Hu ZR, Lu J, Zheng M, Liu RH.
    World J Gastroenterol; 2003 Nov; 9(11):2490-6. PubMed ID: 14606082
    [Abstract] [Full Text] [Related]

  • 6. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
    Ucar F, Sezer S, Ginis Z, Ozturk G, Albayrak A, Basar O, Ekiz F, Coban S, Yuksel O, Armutcu F, Akbal E.
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
    [Abstract] [Full Text] [Related]

  • 7. Platelet count to spleen diameter ratio non-invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis.
    Sheptulina A, Shirokova E, Nekrasova T, Blum H, Ivashkin V.
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1956-1962. PubMed ID: 27059170
    [Abstract] [Full Text] [Related]

  • 8. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
    Li Q, Li W, Huang Y, Chen L.
    J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
    [Abstract] [Full Text] [Related]

  • 9. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of transient elastography in assessing liver fibrosis in patients with advanced schistosomiasis japonica.
    Wu S, Tseng Y, Xu N, Yin X, Xie X, Zhang L, Wu W, Zhu W, Wu W, Yao J, Wu Y.
    Parasitol Int; 2018 Jun; 67(3):302-308. PubMed ID: 29355611
    [Abstract] [Full Text] [Related]

  • 11. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
    Wang CC, Liu CH, Lin CL, Wang PC, Tseng TC, Lin HH, Kao JH.
    J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
    [Abstract] [Full Text] [Related]

  • 12. Performance of simple noninvasive scoring systems for the prediction of advanced fibrosis in patients with chronic hepatitis B.
    Lang S, Kütting F, Staub A, Schramowski J, Schramm C, Kasper P, Goeser T, Steffen HM, Demir M.
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1235-1240. PubMed ID: 28885276
    [Abstract] [Full Text] [Related]

  • 13. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.
    Yang LY, Fu J, Peng XF, Pang SY, Gao KK, Chen ZR, He LJ, Wen Z, Wang H, Li L, Wang FH, Yu JK, Xu Y, Gong ST, Xia HM, Liu HY.
    World J Gastroenterol; 2015 May 21; 21(19):5893-900. PubMed ID: 26019453
    [Abstract] [Full Text] [Related]

  • 14. Serum platelet-derived growth factor BB levels: a potential biomarker for the assessment of liver fibrosis in patients with chronic hepatitis B.
    Zhou J, Deng Y, Yan L, Zhao H, Wang G, China HepB-Related Fibrosis Assessment Research Group.
    Int J Infect Dis; 2016 Aug 21; 49():94-9. PubMed ID: 27292607
    [Abstract] [Full Text] [Related]

  • 15. Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.
    Derbala M, Elbadri ME, Amer AM, AlKaabi S, Sultan KH, Kamel YM, Elsayed EH, Avades TY, Chandra P, Shebl FM.
    World J Gastroenterol; 2015 Dec 14; 21(46):13132-9. PubMed ID: 26674154
    [Abstract] [Full Text] [Related]

  • 16. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results.
    Başar O, Yimaz B, Ekiz F, Giniş Z, Altinbaş A, Aktaş B, Tuna Y, Çoban S, Delibaş N, Yüksel O.
    Clin Res Hepatol Gastroenterol; 2013 Apr 14; 37(2):152-8. PubMed ID: 23391746
    [Abstract] [Full Text] [Related]

  • 17. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S, Memon MS, Ghani H, Baloch GH, Jaffery M, Shaikh K.
    J Coll Physicians Surg Pak; 2009 Aug 14; 19(8):478-82. PubMed ID: 19651008
    [Abstract] [Full Text] [Related]

  • 18. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
    Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, Su GL, Ghosh M, Wright EC, HALT-C Trial Group.
    Hepatology; 2008 Mar 14; 47(3):789-98. PubMed ID: 18175357
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B.
    Xu B, Zhou NM, Cao WT, Li XJ.
    World J Gastroenterol; 2018 Oct 07; 24(37):4272-4280. PubMed ID: 30310260
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic potential of serum matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as non-invasive markers of hepatic fibrosis in patients with HCV related chronic liver disease.
    El-Gindy I, El Rahman AT, El-Alim MA, Zaki SS.
    Egypt J Immunol; 2003 Oct 07; 10(1):27-35. PubMed ID: 15719620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.